The absence of clinical trial data below 2.5 mg is the biggest caveat in the entire microdosing conversation
It can be assayed by spectrophotometry by using the GSH-recycling method or alternatively by HPLC [39, 40]
Not sure whether MOTS-c, NAD+, or both fits your protocol
This doesnt mean Wegovy is a treatment for IBS, but it suggests that some people with IBS may experience unexpected improvements in their symptoms alongside weight loss
Isolated published reports involving small numbers of patients have suggested that patients who have borderline personality disorder, a prior history of violent or aggressive behavior, or alcohol or substance abuse may be at risk for such events
In the 48-week trial, weight loss had not plateaued by the end of the study in the highest dose group